• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » NeuroWave earns CE Mark in the EU

NeuroWave earns CE Mark in the EU

June 29, 2010 By MedCity News

MedCity News logo

By Mary Vanac

Medical device start-up NeuroWave Systems Inc. received CE Mark approval in the European Union for its first product, the NeuroSense anesthesia monitor.

The Cleveland Heights-based company has been developing its brain-monitoring device since 2003, when it licensed the technology from co-inventor and now NeuroWave president, Tatjana Zikov.

“This is a big day for the NeuroWave Systems’ team as we have been working toward this goal for eight years,” Zikov said in a press release. “We are committed to developing innovative brain monitoring technologies for improved cerebral protection and patient outcomes.”

Spun off by Cleveland Medical Devices in 2008, NeuroWave has its own office, licensing agreement and 10 full-time employees to begin marketing NeuroSense — a monitor that measures, analyzes and tracks the brain function of sedated or anesthetized patients.

So far, NeuroWave has used federal grants and contracts and at least one Ohio grant to develop NeuroSense and other brain monitoring technologies — and not a single dollar from investors. The company is pursuing Food & Drug Administration approval to sell its device in the U.S.

The NeuroWave system acquires and displays electroencephalogram signals from both sides of the front part of the brain. Monitoring both sides of the brain is important for detecting anesthesia-related pathologies, such as stroke, that can affect only one part of the brain.

The system quantifies brain activity in patients undergoing general anesthesia or sedation. It also qualifies this information by providing real-time feedback on both cerebral hemispheres. In this way, NeuroSense could improve patient safety and outcomes during anesthesia.

Brain function monitors are not yet the standard of care, Zikov said.

“The benefits of these monitors have been widely publicized. We would be on a good path if these, indeed, become standard of care in years to come,” she said.

The market for brain wave-monitoring devices used during anesthesia is estimated at more than $1 billion a year and growing, according to Cleveland Medical Devices. The market is dominated by Aspect Medical Systems Inc. of Norwood, Mass., according to Neurotech Business Report. Covidien plc (NYSE:COV) acquired Aspect Medical in November 2009, paying $210 million or $12 per share.

Filed Under: Business/Financial News, News Well Tagged With: Anesthesia, NeuroWave Systems Inc.

More recent news

  • Aurora Spine begins first procedures with Aero lumbar fusion system
  • Caranx Medical surgical robot TaviPilot AI software wins FDA clearance
  • InspireMD launches carotid stent in U.S. after FDA approval
  • Neuros Medical raises $56M Series D to support nerve stim tech
  • CorWave reports first-in-human LVAD implant

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy